These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 15775522)

  • 1. [Mechanisms of bone resorption in periodontal disease].
    Ohmori Y
    Clin Calcium; 2001 Mar; 11(3):302-8. PubMed ID: 15775522
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antioxidant alpha-lipoic acid inhibits osteoclast differentiation by reducing nuclear factor-kappaB DNA binding and prevents in vivo bone resorption induced by receptor activator of nuclear factor-kappaB ligand and tumor necrosis factor-alpha.
    Kim HJ; Chang EJ; Kim HM; Lee SB; Kim HD; Su Kim G; Kim HH
    Free Radic Biol Med; 2006 May; 40(9):1483-93. PubMed ID: 16632109
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Human microvascular endothelial cell activation by IL-1 and TNF-alpha stimulates the adhesion and transendothelial migration of circulating human CD14+ monocytes that develop with RANKL into functional osteoclasts.
    Kindle L; Rothe L; Kriss M; Osdoby P; Collin-Osdoby P
    J Bone Miner Res; 2006 Feb; 21(2):193-206. PubMed ID: 16418775
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cytokine pattern determines the progression of experimental periodontal disease induced by Actinobacillus actinomycetemcomitans through the modulation of MMPs, RANKL, and their physiological inhibitors.
    Garlet GP; Cardoso CR; Silva TA; Ferreira BR; Avila-Campos MJ; Cunha FQ; Silva JS
    Oral Microbiol Immunol; 2006 Feb; 21(1):12-20. PubMed ID: 16390336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cross-reactive adaptive immune response to oral commensal bacteria results in an induction of receptor activator of nuclear factor-kappaB ligand (RANKL)-dependent periodontal bone resorption in a mouse model.
    Kawai T; Paster BJ; Komatsuzawa H; Ernst CW; Goncalves RB; Sasaki H; Ouhara K; Stashenko PP; Sugai M; Taubman MA
    Oral Microbiol Immunol; 2007 Jun; 22(3):208-15. PubMed ID: 17488448
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of osteoclast differentiation and bone resorption by sauchinone.
    Han KY; Yang D; Chang EJ; Lee Y; Huang H; Sung SH; Lee ZH; Kim YC; Kim HH
    Biochem Pharmacol; 2007 Sep; 74(6):911-23. PubMed ID: 17662251
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of receptor activator of nuclear factor kappa B ligand relates to inflammatory bone resorption, with or without occlusal trauma, in rats.
    Yoshinaga Y; Ukai T; Abe Y; Hara Y
    J Periodontal Res; 2007 Oct; 42(5):402-9. PubMed ID: 17760817
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone and bone related biochemical examinations. Bone and collagen related metabolites. Regulatory mechanisms of osteoclast differentiation and function].
    Takahashi N
    Clin Calcium; 2006 Jun; 16(6):940-47. PubMed ID: 16751689
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Osteoclast culture and resorption assays.
    Bradley EW; Oursler MJ
    Methods Mol Biol; 2008; 455():19-35. PubMed ID: 18463808
    [TBL] [Abstract][Full Text] [Related]  

  • 10. 1'-Acetoxychavicol acetate inhibits RANKL-induced osteoclastic differentiation of RAW 264.7 monocytic cells by suppressing nuclear factor-kappaB activation.
    Ichikawa H; Murakami A; Aggarwal BB
    Mol Cancer Res; 2006 Apr; 4(4):275-81. PubMed ID: 16603641
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Evidence of the presence of T helper type 17 cells in chronic lesions of human periodontal disease.
    Cardoso CR; Garlet GP; Crippa GE; Rosa AL; Júnior WM; Rossi MA; Silva JS
    Oral Microbiol Immunol; 2009 Feb; 24(1):1-6. PubMed ID: 19121062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Osteoclast differentiation and bone resorption in multicentric reticulohistiocytosis.
    Adamopoulos IE; Wordsworth PB; Edwards JR; Ferguson DJ; Athanasou NA
    Hum Pathol; 2006 Sep; 37(9):1176-85. PubMed ID: 16938523
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Osteoclast precursors: cytokine-stimulated immunomodulators of inflammatory bone disease.
    Boyce BF; Schwarz EM; Xing L
    Curr Opin Rheumatol; 2006 Jul; 18(4):427-32. PubMed ID: 16763465
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Paeonol inhibits RANKL-induced osteoclastogenesis by inhibiting ERK, p38 and NF-kappaB pathway.
    Tsai HY; Lin HY; Fong YC; Wu JB; Chen YF; Tsuzuki M; Tang CH
    Eur J Pharmacol; 2008 Jun; 588(1):124-33. PubMed ID: 18495114
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experimental periodontitis in mice selected for maximal or minimal inflammatory reactions: increased inflammatory immune responsiveness drives increased alveolar bone loss without enhancing the control of periodontal infection.
    Trombone AP; Ferreira SB; Raimundo FM; de Moura KC; Avila-Campos MJ; Silva JS; Campanelli AP; De Franco M; Garlet GP
    J Periodontal Res; 2009 Aug; 44(4):443-51. PubMed ID: 18973535
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Lipopolysaccharide from Prevotella nigrescens stimulates osteoclastogenesis in cocultures of bone marrow mononuclear cells and primary osteoblasts.
    Chung YH; Chang EJ; Kim SJ; Kim HH; Kim HM; Lee SB; Ko JS
    J Periodontal Res; 2006 Aug; 41(4):288-96. PubMed ID: 16827722
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory bone destruction and osteoimmunology.
    Takayanagi H
    J Periodontal Res; 2005 Aug; 40(4):287-93. PubMed ID: 15966905
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The molecular understanding of osteoclast differentiation.
    Asagiri M; Takayanagi H
    Bone; 2007 Feb; 40(2):251-64. PubMed ID: 17098490
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of RANKL in physiological and pathological bone resorption and therapeutics targeting the RANKL-RANK signaling system.
    Tanaka S; Nakamura K; Takahasi N; Suda T
    Immunol Rev; 2005 Dec; 208():30-49. PubMed ID: 16313339
    [TBL] [Abstract][Full Text] [Related]  

  • 20. TNF-related apoptosis-inducing ligand (TRAIL) induces osteoclast differentiation from monocyte/macrophage lineage precursor cells.
    Yen ML; Tsai HF; Wu YY; Hwa HL; Lee BH; Hsu PN
    Mol Immunol; 2008 Apr; 45(8):2205-13. PubMed ID: 18206242
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.